Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Inventory (2021 - 2025)

Universe Pharmaceuticals (UPC) has disclosed Inventory for 5 consecutive years, with $2.5 billion as the latest value for Q3 2025.

  • Quarterly Inventory rose 43.33% to $2.5 billion in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Sep 2025, up 43.33% year-over-year, with the annual reading at $2.5 billion for FY2025, 43.33% up from the prior year.
  • Inventory hit $2.5 billion in Q3 2025 for Universe Pharmaceuticals, up from $1.7 billion in the prior quarter.
  • In the past five years, Inventory ranged from a high of $2.5 billion in Q3 2025 to a low of $16701.0 in Q3 2022.
  • Historically, Inventory has averaged $845.9 million across 5 years, with a median of $2.5 million in 2021.
  • Biggest five-year swings in Inventory: plummeted 99.32% in 2022 and later surged 961494.97% in 2024.
  • Year by year, Inventory stood at $2.5 million in 2021, then tumbled by 99.32% to $16701.0 in 2022, then skyrocketed by 981.63% to $180643.0 in 2023, then soared by 961494.97% to $1.7 billion in 2024, then soared by 43.33% to $2.5 billion in 2025.
  • Business Quant data shows Inventory for UPC at $2.5 billion in Q3 2025, $1.7 billion in Q3 2024, and $180643.0 in Q3 2023.